Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus

Nature Immunology

Volumn 17, Issue 9, 2016, Pages 1102-1108

  Dejnirattisai, Wanwisa ^a   Supasa, Piyada ^a,b   Wongwiwat, Wiyada ^a   Rouvinski, Alexander ^c,d   Barba Spaeth, Giovanna ^c,d   Duangchinda, Thaneeya ^e   Sakuntabhai, Anavaj ^c,f   Cao Lormeau, Van Mai ^g   Malasit, Prida ^b,e   Rey, Felix A ^c,d   Mongkolsapaya, Juthathip ^a,b   Screaton, Gavin R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b MAHIDOL UNIVERSITY   (Thailand)

^c INSTITUT PASTEUR   (France)

^d Institut Pasteur   (France)

^e NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

^f CNRS   (France)

^g INSTITUT LOUIS MALARDÉ   (French Polynesia)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HUMAN MONOCLONAL ANTIBODY; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PROTEIN BINDING;

ADOLESCENT; ANTIBODY DEPENDENT ENHANCEMENT; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS REACTION; DENGUE VIRUS; FEMALE; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY; VIRUS IMMUNITY; VIRUS NEUTRALIZATION; ZIKA FEVER; ZIKA VIRUS; BLOOD; CELL CULTURE; DENGUE; EPITOPE MAPPING; GUILLAIN-BARRE SYNDROME; IMMUNOLOGY; METABOLISM; MICROCEPHALY; PHYSIOLOGY; SOUTH AMERICA; VIRUS REPLICATION; ZIKA VIRUS INFECTION;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY-DEPENDENT ENHANCEMENT; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CROSS REACTIONS; DENGUE; DENGUE VIRUS; EPITOPE MAPPING; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNODOMINANT EPITOPES; MALE; MICROCEPHALY; PROTEIN BINDING; SOUTH AMERICA; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 84976292755     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3515     Document Type: Article

References (48)

1. Musso, D., & Gubler, D.J. Zika Virus. Clin. Microbiol. Rev. 29, 487-524 (2016).
2. Lazear, H.M., & Diamond, M.S. Zika virus: new clinical syndromes and its emergence in the western hemisphere. J. Virol. 90, 4864-4875 (2016
3. World Health Organization. Zika Virus Fact sheet. http://www.who.int/mediacentre/factsheets/zika/en/(2016).
4. Duffy, M.R. et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N. Engl. J. Med. 360, 2536-2543 (2009).
5. Cao-Lormeau, V.M. et al. Zika virus, French Polynesia, South Pacific, 2013. Emerg. Infect. Dis. 20, 1085-1086 (2014).
6. Zanluca, C. et al. First report of autochthonous transmission of Zika virus in Brazil. Mem. Inst. Oswaldo Cruz 110, 569-572 (2015).
7. Campos, G.S., Bandeira, A.C., & Sardi, S.I. Zika virus outbreak, Bahia, Brazil. Emerg. Infect. Dis. 21, 1885-1886 (2015).
8. Cao-Lormeau, V.M. et al. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387, 1531-1539 (2016).
9. Teixeira, M.G., da Conceição N Costa, M., de Oliveira, W.K., Nunes, M.L., & Rodrigues, L.C. The epidemic of Zika virus-related microcephaly in Brazil: detection, control, etiology, and future scenarios. Am. J. Public Health 106, 601-605 (2016).
10. Mlakar, J. et al. Zika virus associated with microcephaly. N. Engl. J. Med. 374, 951-958 (2016).
11. World Health Organization. Zika emergency. http://www.who.int/mediacentre/news/statements/2016/1st-emergency-committee-zika/en/(2016).
12. Musso, D., Cao-Lormeau, V.M., & Gubler, D.J. Zika virus: following the path of dengue and chikungunya?. Lancet 386, 243-244 (2015).
13. Cardoso, C.W. et al. Outbreak of exanthematous illness associated with Zika, chikungunya, and dengue viruses, Salvador, Brazil. Emerg. Infect. Dis. 21, 2274-2276 (2015).
14. Teixeira, M.G. et al. East/Central/South African genotype chikungunya virus, Brazil, 2014. Emerg. Infect. Dis. 21, 906-907 (2015).
15. Weaver, S.C., & Lecuit, M. Chikungunya virus and the global spread of a mosquito-borne disease. N. Engl. J. Med. 372, 1231-1239 (2015).
16. Guzman, M.G., & Harris, E. Dengue. Lancet 385, 453-465 (2015).
17. Morrison, T.E. Reemergence of chikungunya virus. J. Virol. 88, 11644-11647 (2014).
18. Brathwaite Dick, O. et al. The history of dengue outbreaks in the Americas. Am. J. Trop. Med. Hyg. 87, 584-593 (2012).
19. Castanha, P.M. et al. Force of infection of dengue serotypes in a population-based study in the northeast of Brazil. Epidemiol. Infect. 141, 1080-1088 (2013).
20. Braga, C. et al. Seroprevalence and risk factors for dengue infection in socio-economically distinct areas of Recife, Brazil. Acta Trop. 113, 234-240 (2010).
21. Screaton, G., Mongkolsapaya, J., Yacoub, S., & Roberts, C. New insights into the immunopathology and control of dengue virus infection. Nat. Rev. Immunol. 15, 745-759 (2015).
22. Buathong, R. et al. Detection of Zika virus infection in Thailand, 2012-2014. Am. J. Trop. Med. Hyg. 93, 380-383 (2015).
23. Lanciotti, R.S. et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg. Infect. Dis. 14, 1232-1239 (2008).
24. Guzman, M.G. et al. Neutralizing antibodies after infection with dengue 1 virus. Emerg. Infect. Dis. 13, 282-286 (2007).
25. Sabin, A.B. Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1, 30-50 (1952).
26. Guzman, M.G. et al. Dengue: a continuing global threat. Nat. Rev. Microbiol. 8 Suppl, S7-S16 (2010
27. Dejnirattisai, W. et al. A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat. Immunol. 16, 170-177 (2015).
28. Halstead, S.B., & O?Rourke, E.J. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J. Exp. Med. 146, 201-217 (1977).
29. Halstead, S.B., & O?Rourke, E.J. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265, 739-741 (1977).
30. Zompi, S., & Harris, E. Animal models of dengue virus infection. Viruses 4, 62-82 (2012).
31. Brandt, W.E., McCown, J.M., Gentry, M.K., & Russell, P.K. Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect. Immun. 36, 1036-1041 (1982).
32. Rouvinski, A. et al. Recognition determinants of broadly neutralizing human antibodies against dengue viruses. Nature 520, 109-113 (2015).
33. Barba-Spaeth, G. et al. Structural basis of potent antibody cross-neutralization between Zika and Dengue viruses. Nature (in the press).
34. Calvet, G. et al. Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect. Dis.16, 653-660 (2016).
35. Martines, R.B. et al. Notes from the Field: Evidence of Zika virus infection in brain and placental tissues from two congenitally infected newborns and two fetal losses-Brazil, 2015. MMWR Morb. Mortal. Wkly. Rep. 65, 159-160 (2016).
36. Meaney-Delman, D. et al. Zika virus infection among U.S. pregnant travelers-August 2015-February 2016. MMWR Morb. Mortal. Wkly. Rep. 65, 211-214 (2016).
37. Sarno, M. et al. Zika virus infection and stillbirths: a case of hydrops fetalis, hydranencephaly and fetal demise. PLoS Negl. Trop. Dis. 10, e0004517 (2016).
38. Cugola, F.R. et al. The Brazilian Zika virus strain causes birth defects in experimental models. Nature 534, 267-271 (2016).
39. Miner, J.J. et al. Zika virus infection during pregnancy in mice causes placental damage and fetal demise. Cell 165, 1081-1091 (2016).
40. Li, C. et al. Zika virus disrupts neural progenitor development and leads to microcephaly in mice. Cell Stem Cell 19, 1-7 (2016).
41. Dang, J. et al. Zika virus depletes neural progenitors in human cerebral organoids through activation of the innate immune receptor TLR3. Cell Stem Cell doi: 10.1016/j. stem.2016.04.014 (6 May 2016).
42. Garcez, P.P. et al. Zika virus impairs growth in human neurospheres and brain organoids. Science 352, 816-818 (2016).
43. Brasil, P. et al. Zika virus infection in pregnant women in Rio de Janeiro-preliminary report. N. Engl. J. Med. doi: 10.1056/NEJMoa1602412 (4 March 2016).
44. Cauchemez, S. et al. Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study. Lancet 387, 2125-2132 (2016).
45. Stiasny, K., Kiermayr, S., Holzmann, H., & Heinz, F.X. Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. J. Virol. 80, 9557-9568 (2006).
46. Paul, L.M. et al. Dengue virus antibodies enhance Zika virus infection. bioRxiv 10.1101/050112 (2016).
47. World Health Organization (WHO) Strategic Advisory Group of Experts. Dengue vaccine. http://www.who.int/immunization/sage/meetings/2016/april/SAGE-April-2016- Meeting-Web-summary.pdf?.ua=1 (2016
48. Mongkolsapaya, J. et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 9, 921-927 (2003